Mutual of America Capital Management LLC Cuts Stake in HCA Healthcare, Inc. (NYSE:HCA)

Mutual of America Capital Management LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,203 shares of the company’s stock after selling 101 shares during the period. Mutual of America Capital Management LLC’s holdings in HCA Healthcare were worth $8,018,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. GAMMA Investing LLC grew its stake in HCA Healthcare by 40,527.3% in the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company’s stock worth $5,887,850,000 after purchasing an additional 1,699,713 shares in the last quarter. Barclays PLC grew its stake in HCA Healthcare by 85.7% in the fourth quarter. Barclays PLC now owns 1,061,891 shares of the company’s stock worth $318,727,000 after purchasing an additional 489,916 shares in the last quarter. Two Sigma Investments LP grew its stake in HCA Healthcare by 12,016.0% in the fourth quarter. Two Sigma Investments LP now owns 467,437 shares of the company’s stock worth $140,301,000 after purchasing an additional 463,579 shares in the last quarter. Metropolis Capital Ltd acquired a new position in HCA Healthcare in the first quarter worth about $117,984,000. Finally, Maj Invest Holding A S acquired a new position in HCA Healthcare in the first quarter worth about $109,823,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HCA has been the subject of a number of research reports. Guggenheim initiated coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a “neutral” rating for the company. Morgan Stanley cut their price target on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a report on Monday, July 28th. Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a report on Wednesday, July 16th. Finally, Robert W. Baird reaffirmed a “neutral” rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Nine research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $395.69.

Insider Activity

In other news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $366.08 on Thursday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The stock has a fifty day moving average of $369.84 and a 200-day moving average of $348.28. The company has a market capitalization of $85.66 billion, a PE ratio of 15.39, a price-to-earnings-growth ratio of 1.14 and a beta of 1.39. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the prior year, the firm earned $5.50 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.